News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nebius plunged after a neocloud batch, prompting a tactical buy.
  • Trade details: entry $182.57, stop $150, target $280 over 180 trading days.
  • Recommendation notes position size should reflect Nebius's high-risk profile.
  • Seaport Therapeutics (SPTX) pitched as a post-IPO rebound trade with a tight float (~13.8M shares).
  • SPTX trades near $1.09B market cap with roughly 3.7M shares short, and bullish technical momentum.
  • Suggested SPTX trade sizes a mid-term long with defined entries, stops, and targets to limit downside.

Latest Articles

Barnes & Noble College First Day Complete® Expands to 263 Campuses Representing More Than 1.43 Million Students

Barnes & Noble College First Day Complete® Expands to 263 Campuses Representing More Than 1.43 Million Students

Barnes & Noble Education, Inc. announced the expansion of its First Day Complete® program through Barnes & Noble College, now offered at 263 college campuses across 40 states, covering more than 1.43 million students for the Fall 2026 term. The program integrates course material costs into tuition or course charges, delivering significant savings a…

Ming Shing Group Holdings Limited Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

Ming Shing Group Holdings Limited Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

Ming Shing Group Holdings Limited (NASDAQ: PMA), a Hong Kong-based wet trades services provider, announced that it received a notice from Nasdaq indicating non-compliance with minimum stockholders’ equity requirements due to reported net losses and comprehensive losses for recent fiscal years. The company must submit a compliance plan within 45 day…

Goldman Sachs to Buy LCN Capital Partners in Deal Valued Up to $410 Million

Goldman Sachs to Buy LCN Capital Partners in Deal Valued Up to $410 Million

Goldman Sachs Group Inc. has agreed to acquire LCN Capital Partners, a specialist manager of sale-leaseback, build-to-suit and triple net lease real estate assets that oversees about $3 billion in assets as of June 30, 2026. The upfront payment is roughly $260 million, with up to $150 million in deferred and contingent payouts tied to long-term per…

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox Imaging Ltd., traded on NASDAQ as NNOX, announced that its subsidiary Nanox AI entered into an exclusive reseller agreement with UK-based Vertec Scientific for the commercialization of its AI-driven bone assessment software, Nanox.AI Bone Solution (HealthOST), in the United Kingdom. The three-year agreement includes minimum annual license com…

How to Position Bond ETFs as Yields Climb

How to Position Bond ETFs as Yields Climb

With selling in long-duration Treasuries driving yields higher, funds that reset coupons or sit at the ultra-short end are showing resilience. Floating-rate government ETFs and ultra-short Treasury wrappers have posted positive returns in 2026, while long-duration Treasury ETFs have taken losses. A playbook of core floating, cash-like ultra-short, …

Baidu tumbles after Q2 miss — valuation looks tempting but risks remain

Baidu tumbles after Q2 miss — valuation looks tempting but risks remain

Baidu fell sharply in premarket trading after reporting second-quarter results that missed consensus on both earnings and revenue. Core advertising sales continue to contract while AI Cloud revenue is growing rapidly, but management warned of increased AI spending in the back half of 2026. Technical indicators are firmly bearish and consensus earni…

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

SciSparc Ltd., traded on Nasdaq as SPRC, announced that its majority-owned subsidiary NeuroThera Labs has completed a C$5.4 million private placement financing. SciSparc invested C$2.7 million, increasing its ownership to approximately 44.6% of NeuroThera, valuing its stake around C$30 million. NeuroThera plans to use proceeds for working capital a…

Trident Digital Tech Holdings (Nasdaq: TDTH) Executes Joint Venture to Deploy the IRMA AI Engine to Three Continents and Markets Representing Approximately 9.4 Million Businesses With Digital Innovations Group

Trident Digital Tech Holdings (Nasdaq: TDTH) Executes Joint Venture to Deploy the IRMA AI Engine to Three Continents and Markets Representing Approximately 9.4 Million Businesses With Digital Innovations Group

Trident Digital Tech Holdings announced a definitive joint venture agreement with U.S.-based Digital Innovations Group to establish IRMA Asia Pte. Ltd., a 50/50 joint venture deploying the IRMA AI Engine across Asia, the Middle East, and Africa. The venture targets approximately 9.4 million small and medium-sized businesses, aiming to commercialize…

Velaura AI Tops $1 Billion Valuation After $110 Million Series A Round

Velaura AI Tops $1 Billion Valuation After $110 Million Series A Round

Velaura AI said on Aug 18 that it raised $110 million in a Series A financing, valuing the startup at more than $1 billion. The round was led by Seligman Ventures, included new investor Capricorn Investment Group, and drew participation from existing backers Samsung Catalyst Fund, StepStone Group and Maverick Silicon. The company develops low-power…

BIM Birlesik Magazalar Jumps After Far-Above-Expectations Q2 Results

BIM Birlesik Magazalar Jumps After Far-Above-Expectations Q2 Results

Shares of BIM Birlesik Magazalar AS climbed 6.2% to 405.75 TRY after the Turkish discount retailer reported second-quarter 2026 results that notably outperformed analyst expectations. The company delivered an 8 billion TRY net profit, sales of 221.9 billion TRY in real terms, and EBITDA of 13.57 billion TRY, while expanding its global store base be…

Safe Pro Awarded Subcontract for Artificial Intelligence Powered Demining Software Under U.S. Department of State Program

Safe Pro Awarded Subcontract for Artificial Intelligence Powered Demining Software Under U.S. Department of State Program

Safe Pro Group Inc., a Nasdaq-listed AI defense technology firm, has been awarded a subcontract worth approximately $180,000 by the U.S. Department of State. The contract includes delivery of specialized AI-enabled GPU laptops equipped with the company's patented Spotlight OnSight software designed for explosive threat detection and mapping to supp…

ShengShu Technology Weighs Hong Kong IPO That Could Top $500 Million

ShengShu Technology Weighs Hong Kong IPO That Could Top $500 Million

ShengShu Technology, the developer of the Vidu AI video generator and a portfolio company of Alibaba, is in preliminary discussions to list in Hong Kong in a transaction that could raise more than $500 million. The company has retained China International Capital Corp. and Citic Securities Co. to advise on the proposed offering, which may take plac…

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Humacyte, a US-based biotech company, announced the first commercial implantations of Symvess, their FDA-approved bioengineered human blood vessel, performed by Dr. Jeromy Brink in Arizona. Symvess provides an off-the-shelf vascular graft option for emergency limb salvage surgeries, reducing the need for vein harvesting. This milestone marks a sign…

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

CareCloud, Inc. (Nasdaq: CCLD) has partnered with KabaFusion to co-develop LailaCare, a first-of-its-kind AI-powered integrated platform designed to streamline and modernize home infusion therapy workflows and specialty pharmacy services. The platform aims to unify referral intake, patient engagement, revenue cycle management, and operational effic…

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

Elutia Inc. has finalized the sale of its SimpliDerm human acellular dermal matrix business for up to $11 million, including an $8 million upfront payment. The transaction strengthens Elutia’s balance sheet with non-dilutive capital and enables the company to focus on developing and commercializing NXT-41x, an antibiotic-eluting biomatrix targeting…

Unusual Whales and Siebert Financial Announce Strategic Partnership to Launch New Series of ETFs

Unusual Whales and Siebert Financial Announce Strategic Partnership to Launch New Series of ETFs

Siebert Financial Corp. announced a strategic partnership with Unusual Whales to develop and launch new exchange-traded funds (ETFs) that leverage unique market intelligence such as political trading disclosures and unusual options activity. This collaboration combines Unusual Whales’ data access and community with Siebert’s financial expertise and…